GlaxoSmithKline, Vir Say U.S. to Buy 600,000 More Covid Doses

The agreement includes the option for the U.S. to buy additional doses in the second quarter, the companies say.

Related Keywords

,Pharmaceuticals ,Stocks ,Business Of Covid ,Investing Stocks ,Covid ,Investing ,Covid 19 ,